WHO Approves HCV Rapid Diagnostic Test

WHO acceptance of the test comes at a time when direct acting antivirals, new and highly effective medicines for HCV, are becoming increasingly affordable and available in low- and middle-income countries.

The World Health Organization has prequalified its first hepatitis C rapid diagnostic test and says this action opens the door to expanded treatment of the disease in low- and middle-income countries. "The fact that we now have very effective new medicines for HCV needs to be bolstered by effective and affordable diagnostics," said Dr. Suzanne Hill, WHO's director for Essential Medicines and Health Products. "This new quality-assured test is good news for the many people awaiting diagnosis and treatment."

The newly prequalified test, SD BIOLINE HCV by Standard Diagnostics, Inc. (South Korea), is a point-of-care diagnostic, making it particularly appropriate for low-resourced countries where testing laboratories and trained personnel may be scarce. Resembling a pharmacy pregnancy test, it does not require hospital facilities or electricity and can be performed by health workers with limited training, and the test provides a result within 20 minutes.

WHO acceptance of the test comes at a time when direct acting antivirals, new and highly effective medicines for HCV, are becoming increasingly affordable and available in low- and middle-income countries.

"The majority of people with chronic hepatitis C don't know they have the infection and miss the opportunity to be cured," said Dr. Gottfried Hirnschall, WHO's director for the Department of HIV and Global Hepatitis Programme. "Making the first WHO prequalified test available in countries can greatly contribute to achieving the goal of eliminating hepatitis."

Only a few HCV rapid tests are on the market "and they are either not quality-assured or too expensive for countries with limited resources. This means that patients may potentially be misdiagnosed – either as false positives or false negatives. The newly prequalified test is expected to be more affordable, as well as guaranteeing quality, safety and performance. Agencies that procure or purchase health products for low-resource countries, such as Médecins Sans Frontières and UNITAID, have been waiting for such a test in order to scale up diagnosis and treatment," WHO reported.

"One of the chief obstacles to effective testing and treatment of HCV has been a lack of suitable diagnostic tests, with the result that only a small minority of people infected with HCV are aware of their status," said UNITAID Executive Director Lelio Marmora. "We are therefore greatly encouraged by the news that a WHO-prequalified rapid diagnostic test for HCV can now be made available to those most in need."

Product Showcase

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

  • Preventative Heat Safety

    Dehydration and heat exposure impair physical and cognitive performance. Proper hydration boosts heat stress resilience, but hydration needs are highly individualized and hard to predict across a workforce. Connected Hydration® empowers industrial athletes to stay safe through behavioral interventions, informed by sports science, and equips safety teams with critical insights to anticipate high-risk situations and adapt to evolving environmental factors. Curious about applying the latest in sports science based hydration strategies for industrial athletes? Stop by booth #1112 at AIHA or schedule a free demo today at https://epcr.cc/demo. Read More

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

Featured